Holdsworth Mark T, Raisch Dennis W, Winter Stuart S, Frost Jami D, Moro Michele A, Doran Nivine H, Phillips Joyce, Pankey Jan M, Mathew Prasad
Pharmacy & Pediatrics, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131-1066, USA.
Ann Pharmacother. 2003 Jan;37(1):17-22. doi: 10.1345/aph.1C088.
To compare the efficacy of 3 different pharmacologic regimens to relieve pain and distress in children with cancer undergoing bone marrow aspirations (BMAs) and lumbar punctures (LPs).
Retrospective cohort study with crossovers for some patients.
The pain and distress ratings of patients undergoing BMAs (n = 73) and LPs (n = 105) were examined in a comparison of 3 different interventions: (1) a topical eutectic mixture of lidocaine and prilocaine (EMLA cream), (2) oral midazolam and EMLA cream, or (3) propofol/fentanyl general anesthesia. The choice of the intervention depended on patient/parent request. A validated faces pain scale was completed by the child or parent following each BMA or LP. The faces pain scale includes ratings of the severity of pain (from 0 = none to 5 = severe) and ratings of how frightened (from 0 = not scared to 5 = scared) the child was prior to each procedure. Comparisons of the pain and distress ratings were made among all patients for their first procedure and also within individual patients who had received >1 of the 3 interventions. Independent comparisons between the first treatments received by each patient were analyzed using Kruskal-Wallis tests. Comparisons of different crossover treatments received by individual patients were analyzed using Wilcoxon tests.
For all first procedures, mean +/- SD pain and distress ratings during LPs were significantly lower when propofol/fentanyl was used (n = 43; 0.4 +/- 1.0 and 1.4 +/- 1.7) versus either EMLA (n = 29; 2.4 +/- 1.7 and 2.9 +/- 1.9) or midazolam/EMLA (n = 33; 2.4 +/- 1.8 and 2.7 +/- 1.8), respectively. Pain and distress ratings during BMAs were also significantly lower with propofol/fentanyl (n = 29; 0.5 +/- 1.0 and 1.2 +/- 1.7) versus EMLA (n = 21; 3.5 +/- 1.6 and 3.3 +/- 1.8) or midazolam/EMLA (n = 23; 3.3 +/- 1.5 and 3.0 +/- 1.9), respectively. When data were analyzed within each patient, these differences were also present.
Children receiving propofol/fentanyl general anesthesia experienced significantly less procedure-related pain and distress than did those receiving either EMLA or oral midazolam/EMLA.
比较3种不同药物治疗方案缓解接受骨髓穿刺(BMA)和腰椎穿刺(LP)的癌症患儿疼痛和痛苦的疗效。
对部分患者进行交叉的回顾性队列研究。
在比较3种不同干预措施时,对接受BMA(n = 73)和LP(n = 105)的患者的疼痛和痛苦评分进行了检查:(1)利多卡因和丙胺卡因的外用共熔混合物(EMLA乳膏),(2)口服咪达唑仑和EMLA乳膏,或(3)丙泊酚/芬太尼全身麻醉。干预措施的选择取决于患者/家长的要求。每次BMA或LP后,由儿童或家长完成经过验证的面部疼痛量表。面部疼痛量表包括疼痛严重程度评分(从0 =无疼痛到5 =严重疼痛)以及每次操作前儿童的恐惧程度评分(从0 =不害怕到5 =害怕)。对所有患者首次操作时的疼痛和痛苦评分进行比较,同时也对接受过3种干预措施中1种以上的个体患者进行比较。使用Kruskal-Wallis检验分析每位患者首次接受治疗之间的独立比较。使用Wilcoxon检验分析个体患者接受的不同交叉治疗之间的比较。
对于所有首次操作,使用丙泊酚/芬太尼时(n = 43;0.4±1.0和1.4±1.7),LP期间的平均±标准差疼痛和痛苦评分显著低于使用EMLA(n = 29;2.4±1.7和2.9±1.9)或咪达唑仑/EMLA(n = 33;2.4±1.8和2.7±1.8)时。BMA期间使用丙泊酚/芬太尼时(n = 29;0.5±1.0和1.2±1.7)的疼痛和痛苦评分也显著低于使用EMLA(n = 21;3.5±1.6和3.3±1.8)或咪达唑仑/EMLA(n = 23;3.3±1.5和3.0±1.9)时。当在每位患者内分析数据时,这些差异也存在。
接受丙泊酚/芬太尼全身麻醉的儿童与接受EMLA或口服咪达唑仑/EMLA的儿童相比,与操作相关的疼痛和痛苦明显更少。